Commercialization of biopolymers

A large variety of biopolymers, such as polysaccharides, polyesters, and polyamides, are naturally synthesized by microorganisms. These biopolymers range from viscous solutions to plastics and their physical properties which are dependent on the composition and molecular weight of the polymer. Genetic engineering of microorganisms has provided an enormous potential for the biotechnological production of biopolymers with desired properties suitable for medical application such as tissue engineering, material science, drug delivery and bioplastics. There are several benefits in commercializing biopolymers mostly for sustainable development, renewability and eco-friendly aspects. Bioplastics can be manufactured mainly with three different methods, one is modifying naturally occurring polymers such as starch, cellulose. Second, is by polymerizing bio-based monomers that are produced by fermentation and the last one, as mentioned earlier, by genetically modified microbes and plants. There are several technologies and processes designed for biopolymer production that include extrusion, film blowing, thermoforming, fermentation, injection moulding, etc.

  • Processing technologies
  • Raw materials resource base
  • Transition to bio based products
  • Potential benefits of biopolymer industries
  • Products of biopolymers

Related Conference of Commercialization of biopolymers

August 19-20, 2019 |

23rd International Conference on Advanced Materials & Nanotechnology

Tokyo, Japan | ANA Crowne Plaza Narita |
21-22 October 2019

25th World Congress on Advanced Materials

Singapore
February 24-25, 2020

5th Annual Conference and Expo on Biomaterials

Berlin, Germany
March 16-17, 2020

World Congress on Carbon and Advanced Energy Materials

Sydney, Australia
April 27-28, 2020

3rd European Food Chemistry & Nutrition Congress

Florence | Italy

Commercialization of biopolymers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in